A facilitated transport process that removes the endogenous cannabinoid ana
ndamide from extracellular spaces has been identified. Once transported int
o the cytoplasm, fatty acid amide hydrolase (FAAH) is responsible for metab
olizing the accumulated anandamide. We propose that FAAH contributes to ana
ndamide uptake by creating and maintaining an inward concentration gradient
for anandamide. To explore the role of FAAH in anandamide transport, we ex
amined anandamide metabolism and uptake in RBL-2H3 cells, which natively ex
press FAAH, as well as wild-type Hela cells that lack FAAH. RBL-2H3 and FAA
H-transfected Hela cells demonstrated a robust ability to metabolize ananda
mide compared with vector-transfected HeLa cells. This activity was reduced
to that observed in wild-type HeLa cells upon the addition of the FAAH inh
ibitor methyl arachidonyl fluorophosphonate. Anandamide uptake was reduced
in a dose-dependent manner by various FAAH inhibitors in both RBL-2H3 cells
and wild-type Hela cells. Anandamide uptake studies in wild-type HeLa cell
s showed that only FAAH inhibitors structurally similar to anandamide decre
ased anandamide uptake. Because there is no detectable FAAH activity in wil
d-type HeLa cells, these FAAH inhibitors are probably blocking uptake via a
ctions on a plasma membrane transport protein. Phenylmethylsulfonyl fluorid
e, a FAAH inhibitor that is structurally unrelated to anandamide, inhibited
anandamide uptake in RBL-2H3 cells and FAAH-transfected Hela cells, but no
t in wild-type HeLa cells. Furthermore, expression of FAAH in HeLa cells in
creased maximal anandamide transport e-fold compared with wild-type HeLa ce
lls. These results suggest that FAAH facilitates anandamide uptake but is n
ot solely required for transport to occur.